404 papers found
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority studyUpload
Correlations Between Non-Invasive Biomarkers and Fibrosis Scores in Chronic Hepatitis B (Chb) Patients Treated With Tenofovir Disoproxil Fumarate (Tdf) and Tenofovir Alafenamide (Taf) in Phase 3 Clinical TrialsUpload
Impact of Pre-Treatment Plasma HBV Dna Levels on the Rate of Alt Normalization During Antiviral Therapy With Tenofovir Alafenamide (Taf) or Tenofovir Disoproxil Fumarate (Tdf) for Chronic Hepatitis B (Chb)Upload
Maintenance of High Levels of Viral Suppression and Improved Safety Profile of Tenofovir Alafenamide (Taf) Relative to Tenofovir Disoproxil Fumarate (Tdf) in Chronic Hepatitis B Patients Treated for 5 Years in 2 Ongoing Phase 3 StudiesUpload
Missing publications? Search for publications with a matching author name.